What is the news? Bharat Biotech is on the threshold of becoming the second Indian vaccine maker to receive an emergency use approval in the domestic market for a children’s Covid vaccine. The company’s vaccine for children has received a conditional approval from an expert committee of the drug regulator. The next steps will have… Continue reading Covaxin junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance?
What is the News? The Subject Expert Committee (SEC) of the Drugs Controller General of India (DCGI) has recommended granting an emergency use authorisation to Bharat Biotech’s Covaxin for children aged between 2-18. If the DCGI goes ahead and grants approval, it will be the first vaccine to be administered to children in India. What… Continue reading Expert panel okays use of Covaxin in 2-18 age group